Skip to main content
TipRanks
Go Ultimate75% OFF

Standard BioTools (LAB) Financial Statements

476 Followers

Standard BioTools Financial Overview

Standard BioTools's market cap is currently $212.95M. The company's EPS TTM is $-0.11; its P/E ratio is -4.75; Standard BioTools has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 85.33M$ 174.43M$ 106.34M$ 97.95M$ 130.58M
Gross Profit$ 42.54M$ 84.26M$ 50.45M$ 37.05M$ 69.37M
Operating Income$ -93.31M$ -175.24M$ -76.60M$ -116.20M$ -67.46M
EBITDA$ -85.70M$ -118.14M$ -54.46M$ -173.57M$ -44.27M
Net Income$ -74.90M$ -138.88M$ -74.66M$ -190.10M$ -59.24M
Balance Sheet
Cash & Short-Term Investments$ 187.57M$ 292.87M$ 114.89M$ 165.78M$ 28.45M
Total Assets$ 567.75M$ 612.34M$ 323.07M$ 390.31M$ 275.21M
Total Debt$ 30.83M$ 33.00M$ 98.21M$ 102.66M$ 111.65M
Net Debt$ -87.39M$ -133.73M$ 46.51M$ 21.35M$ 83.20M
Total Liabilities$ 143.46M$ 140.62M$ 471.12M$ 471.78M$ 180.62M
Stockholders' Equity$ 424.29M$ 471.72M$ -148.05M$ -81.47M$ 94.60M
Cash Flow
Free Cash Flow$ -82.65M$ -151.81M$ -46.12M$ -93.19M$ -57.33M
Operating Cash Flow$ -74.35M$ -143.45M$ -43.29M$ -89.37M$ -44.06M
Investing Cash Flow$ 24.77M$ 363.17M$ 20.24M$ -88.13M$ -11.95M
Financing Cash Flow$ 570.00K$ -102.62M$ -6.81M$ 230.76M$ 15.96M

Currency in USD

Standard BioTools Earnings and Revenue History

-400M-200M0200M-240 %-160 %-80 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Standard BioTools Liabilities to Assets

0250M500M750M0 %60 %120 %180 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Standard BioTools Cash Flow

-200M-100M0100M200M300M400M201720182019202020212022202320242025OperatingInvestingFinancing

Standard BioTools Forecast EPS vs Actual EPS

-0.1-0.1000.10.1Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss